Thank you for sharing!

Your article was successfully shared with the contacts you provided.
Martin Shkreli, former CEO of Turing Pharmaceuticals, appearing before the House Committee on Oversight and Government Reform during a hearing titled “Developments in the Prescription Drug Market,” on Feb. 4, 2016. Photo: Diego M. Radzinschi/ALM

The biopharmaceutical company co-founded by convicted stock fraudster Martin Shkreli has lost its bid to depose the executive of a generic pharmaceutical company in connection with an antitrust lawsuit, and a Philadelphia federal judge has ordered it to pay the executive’s legal bill.

U.S. District Judge J. Curtis Joyner of the Eastern District of Pennsylvania granted a motion to quash a subpoena issued by Retrophin, in which the company sought to depose an executive at Prinston Pharmaceuticals. The ruling was handed up Wednesday, and docketed with the court Thursday.

This content has been archived. It is available through our partners, LexisNexis® and Bloomberg Law.

To view this content, please continue to their sites.

Not a Lexis Advance® Subscriber?
Subscribe Now

Not a Bloomberg Law Subscriber?
Subscribe Now

Why am I seeing this?

LexisNexis® and Bloomberg Law are third party online distributors of the broad collection of current and archived versions of ALM's legal news publications. LexisNexis® and Bloomberg Law customers are able to access and use ALM's content, including content from the National Law Journal, The American Lawyer, Legaltech News, The New York Law Journal, and Corporate Counsel, as well as other sources of legal information.

For questions call 1-877-256-2472 or contact us at [email protected]

Max Mitchell

Max Mitchell is ALM's Pennsylvania Bureau Chief overseeing The Legal Intelligencer, Delaware Law Weekly and Delaware Business Court Insider. Follow him on Twitter @MMitchellTLI. His email is [email protected]

More from this author


ALM Legal Publication Newsletters

Sign Up Today and Never Miss Another Story.

As part of your digital membership, you can sign up for an unlimited number of a wide range of complimentary newsletters. Visit your My Account page to make your selections. Get the timely legal news and critical analysis you cannot afford to miss. Tailored just for you. In your inbox. Every day.

Copyright © 2021 ALM Media Properties, LLC. All Rights Reserved.